Clinical trials
Dysplasia clinical trials
Below are recruiting dysplasia clinical trials, each written for real people, not researchers. We’re tracking 161 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04117685Recruiting
Global hip dysplasia registry for young children
This trial is a worldwide registry that collects information from children with hip dysplasia or who are at higher risk. It helps researchers understand who is affected and how hip evaluations are done, which can improve future care.
Vancouver, British ColumbiaAges 1 minute–10 years - NCT05869851Recruiting
Infant hip ultrasound study: observe vs bracing
This study looks at babies under 3 months old with certain ultrasound findings of an underdeveloped hip (“hip dysplasia”). It compares outcomes between simply watching the hip and using a brace (when recommended).
Vancouver, British ColumbiaAges Up to 3 months - NCT03061435Recruiting
Screening for anal cancer after high-grade vulvar changes
This trial checks whether anal cancer screening is useful for women age 40 and older who previously had high-grade vulvar pre-cancer (VIN 2/3) or vulvar cancer. It may help find serious problems earlier in people at higher risk.
Toronto, OntarioAges 40 years+ - NCT06342440Recruiting
Early detection of colon cancer and advanced polyps
This study aims to find colorectal cancer and advanced polyps (adenomas) earlier by looking at blood samples. Researchers hope a simple blood test might one day help detect colon cancer before it spreads.
Monrovia, CaliforniaAges 18 years+ - NCT05865028RecruitingPhase 2
Test drug APG-157 for abnormal mouth tissue
This Phase 2 trial studies whether APG-157 can safely improve abnormal cells in the mouth (dysplasia) or early cancer-like changes (carcinoma in situ). You may be eligible if you have a visible, biopsy-proven lesion and can take oral medication while meeting blood and health requirements.
Miami, FloridaAges 18 years+ - NCT04804683Recruiting
FMD and SCAD registry study in Europe and beyond
This trial is a registry, meaning it collects detailed medical information to better understand fibromuscular dysplasia (FMD) and a specific type of heart-vessel dissection (SCAD) linked to FMD. It may help researchers learn who is at risk and guide better care in the future.
BrusselsAges Any age - NCT07529691Recruiting
Physical Activity and Quality of Life in Fibromuscular Dysplasia
This study asks people with fibromuscular dysplasia (an artery condition) about their physical activity and how they're doing in daily life. The information helps doctors understand how the condition affects people's wellbeing and exercise ability.
Nashville, TennesseeAges 18–100 - NCT07569731Recruiting
Understanding Fibrous Dysplasia Through Patient Data and Tissue
This study collects information from patients with fibrous dysplasia (a bone condition where normal bone is replaced by fibrous tissue) and related syndromes to better understand the disease. Researchers will review your medical records, imaging scans, and stored tissue samples to learn more about how the disease develops and progresses.
Bologna, BOAges Any age - NCT07581717Recruiting
Hip Socket Surgery Imaging Study for Children
This study uses MRI scans before and after hip socket surgery to measure how the surgery changes the shape and size of the hip joint. It helps doctors understand which surgical technique works best for children with hip dysplasia (a condition where the hip socket doesn't fully cover the thighbone).
IstanbulAges 2–18 - NCT07287202RecruitingPhase 1/Phase 2
A study of SVG103 for people with certain brain conditions and seizures
This trial tests a drug called SVG103 (Paxalisib) in adults with brain conditions that cause hard-to-control seizures: Focal Cortical Dysplasia Type II, Tuberous Sclerosis Complex, or Hemimegalencephaly. The goal is to see if SVG103 is safe and helps reduce seizures.
Heidelberg, VictoriaAges 18–65 - NCT05349240Recruiting
Treatment-guided endoscopy for moderate to severe esophageal dysplasia
This trial studies a newer approach to treat abnormal, precancer-like changes in the esophagus seen on a special endoscopy test using iodine. It may help prevent progression and spread by targeting moderate to severe dysplasia that appears in a specific, limited pattern.
BeijingAges 18–80 - NCT05081453Recruiting
Early testing and treatment for a specific hip-knee problem
This trial focuses on healthy newborns who were born breech to identify early signs of a knee-tilt/track problem and start treatment sooner if needed. It may help reduce how much the condition affects walking later by addressing it early.
MurciaAges birth–6 months - NCT03231644Recruiting
Registry for fibrous dysplasia and related conditions
This is a patient registry that collects health information from people with fibrous dysplasia, McCune-Albright syndrome, or Mazabraud’s syndrome. It helps researchers understand these conditions better and may support future studies.
Bethesda, MarylandAges Any age - NCT03631420RecruitingPhase 1
Stem cell treatment to prevent lung disease in very premature babies
This Phase 1 trial tests whether giving stem cells into a breathing tube is safe and may help prevent bronchopulmonary dysplasia (BPD), a serious lung condition in very premature infants. It focuses on babies soon after birth who already need breathing support and are at risk.
TainanAges 3 days–2 months - NCT04098744RecruitingPhase 2
Artesunate vaginal inserts for high-grade cervical changes
This Phase 2 study tests whether artesunate vaginal inserts can help treat high-grade abnormal cells on the cervix (CIN2/3). It’s meant for adults who have a confirmed high-grade precancer change and can use birth control during the study.
Fort Myers, FloridaAges 25–100 - NCT04270045Recruiting
Breathing test in babies with bronchopulmonary dysplasia
This trial studies a breathing measurement test (forced oscillometry) in babies who were born early and have bronchopulmonary dysplasia (BPD), a long-term lung condition. It may help doctors better understand how babies’ lungs are working and guide future care.
Kansas City, MissouriAges Any age - NCT04607538Recruiting
Study of knee joint shape and patella dislocations in Faroese teens
This study looks at how knee joint shape differences may relate to repeated kneecap (patella) instability or near-dislocation, and what that means long-term. It specifically includes teens from the Faroe Islands and asks about symptoms and knee function over time.
HvidovreAges 15–20 - NCT04772937Recruiting
Compare two procedures for high-grade abnormal cervix cells
This trial compares two treatments—LLETZ versus LEEP—for high-grade abnormal cells on the cervix. It may help decide which procedure works best and is safest for clearing these abnormal areas.
HerneAges 18 years+ - NCT04795843Recruiting
Exercise and education versus usual care for hip dysplasia
This trial compares a structured exercise and patient education program with standard care in people with hip dysplasia. It may help improve hip and groin pain and function, especially if you are not getting the usual surgery (periacetabular osteotomy, or PAO).
Aarhus NAges 18–50 - NCT04980638RecruitingPhase 2
Check ER004 given in the womb for a genetic tooth-skin disorder
This Phase 2 study tests ER004 put into the amniotic fluid during pregnancy to treat male babies with X-linked hypohidrotic ectodermal dysplasia (XLHED). It also looks at effects in affected male relatives with the same gene change.
Los Angeles, CaliforniaAges 18 years+ - NCT05225311Recruiting
Registry for pregnancies with Ebstein and tricuspid valve issues
This registry collects information about pregnancies where the baby is diagnosed with Ebstein anomaly and/or tricuspid valve dysplasia. It helps doctors learn how these heart conditions affect pregnancies and outcomes, and can support better future care.
Toronto, OntarioAges Any age - NCT05363748Recruiting
Kidney artery fibromuscular dysplasia registry for patients
This registry collects information from people diagnosed with kidney artery fibromuscular dysplasia (or certain similar, “atypical” cases). It helps doctors better understand patterns of the condition and may guide future research and care.
Shanghai, Shanghai MunicipalityAges Any age - NCT05640700Recruiting
Study of vaginal microbiome in HPV-related early cell changes
This study looks at the vaginal “microbiome” (the normal germs and bacteria in the vagina) in people who have had abnormal Pap smear or colposcopy results related to HPV. It may help doctors understand what to monitor and how to better identify early, pre-cancer changes in the cervix.
JerusalemAges 25–70 - NCT05745857RecruitingPhase 2
Scan for early esophagus cancer using infused antibody dyes
This Phase 2 study uses special drug dyes (bevacizumab and cetuximab, each tagged for imaging) during an esophagus scope to help doctors find very early abnormal cells, like low- or high-grade pre-cancer and superficial cancer. If you qualify, the goal is earlier detection and better targeting during diagnosis and treatment.
Groningen, Provincie GroningenAges 18 years+
Hear when a new Dysplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for dysplasia?
- Yes. Clin2 currently lists 161 recruiting dysplasia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a dysplasia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a dysplasia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.